We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
1.Rief, W, Hessel, A, Braehler, E. Somatization symptoms and hypochondriacal features in the general population. Psychosom Med2001; 63(4): 595–602.CrossRefGoogle ScholarPubMed
2
2.Kirmayer, LJ, Robbins, JM. Patients who somatise in primary care: a longitudinal study of cognitive and social characteristics. Psychol Med1996; 26(5): 937–5.CrossRefGoogle ScholarPubMed
3
3.Reid, S, Wessely, S, Crayford, T, Hotopf, M. Frequent attenders with medically unexplained symptoms:service use and costs in secondary care. Br J Psychiatry2002; 180: 248–53.CrossRefGoogle ScholarPubMed
4
4.Nimnuan, C, Hotopf, M, Wessely, S. Medically unexplained symptoms: an epidemiological study in seven specialities. J Psychosom Res2001; 51(1): 361–7.CrossRefGoogle ScholarPubMed
5
5.Nimnuan, C, Rabe-Hesketh, S, Wessely, S, Hotopf, M. How many functional somatic syndromes?J Psychosom Res2001; 51(4): 549–57.CrossRefGoogle ScholarPubMed
6
6.Aggarwal, VR, McBeth, J, Zakrzewska, JM, Lunt, M, Macfarlane, GJ. The epidemiology of chronic syndromes that are frequently unexplained: do they have common associatedfactors?Int J Epidemiol2006; 35(2): 468–76.CrossRefGoogle Scholar
7
7.Katon, WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry2003; 54(3): 216–26.CrossRefGoogle ScholarPubMed
8
8.Simon, GE, VonKorff, M, Piccinelli, M, Fullerton, C, Ormel, J. An international study of therelation between somatic symptoms and depression. N Engl J Med1999; 341(18): 1329–35.CrossRefGoogle Scholar
9
9.Newman, MG, Clayton, L, Zuellig, A, Cashman, L, Arnow, B, Dea, R, Taylor, CB. The relationship of childhood sexual abuse and depression with somatic symptoms and medical utilisation. Psychol Med2000; 30(5): 1063–77.CrossRefGoogle Scholar
10
10.Ohayon, MM, Schatzberg, AF. Using chronic pain to predict depressive morbidity in the general population. Arch Gen Psychiatry2003; 60(1): 39–47.CrossRefGoogle ScholarPubMed
11
11.Kirmayer, LJ, Robbins, JM, Dworkind, M, Yaffe, MJ. Somatisation and the recognition of depression and anxiety in primary care. Am J Psychiatry1993; 150(5): 734–41.Google ScholarPubMed
13.Harkness, EF, Macfarlane, GJ, Silman, AJ, McBeth, J. Is musculoskeletal pain more common now than 40 years ago?: Two population-based cross-sectional studies. Rheumatology (Oxford)2005; 44(7): 890–5.CrossRefGoogle ScholarPubMed
14
14.Rief, W, Hiller, W. Toward empirically based criteria for the classification of somatoform disorders. J Psychosom Res1999; 46: 507–18.CrossRefGoogle ScholarPubMed
15
15.Sharpe, M, Carson, A. Unexplained somatic symptoms, functional syndromes, and somatisation: do we need a paradigm shift?Ann Intern Med2001; 134: 926–30.CrossRefGoogle ScholarPubMed
16
16.Wise, TN, Birkett-Smith, M. The somatoform disorders for DSM-V: the need for changes in process and content. Psychosomatics2002; 43: 437–40.CrossRefGoogle ScholarPubMed
17
17.De Gucht, V, Fischler, B. Somatization: a critical review of conceptual and methodological issues. Psychosomatics2002; 43: 1–9.CrossRefGoogle ScholarPubMed
18
18.Mayou, R, Kirmayer, LJ, Simon, G, Kroenke, K, Sharpe, M. Somatoform disorders: time for a new approach in DSM-V. Am J Psychiatry2005; 162: 847–55.CrossRefGoogle ScholarPubMed
19
19.Escobar, JI, Manu, P, Matthews, D, Lane, T, Swartz, M, Canino, G. Medically unexplained physical symptoms, somatisation disorder and abridged somatisation: studies with the Diagnostic Interview Schedule. Psychiatr Dev1989; 7(3): 235–45.Google ScholarPubMed
20
20.Spitzer, RL, Kroenke, K, Linzer, M, Hahn, SR, Williams, JB, deGruy, FV3rd, Brody, D, Davies, M. Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 Study. JAMA1995; 274(19): 1511–7.CrossRefGoogle ScholarPubMed
21
21.Hiller, W, Rief, W, Fichter, MM. How disabled are patients with somatoformdisorders?Gen Hosp Psychiatry1997; 19(6): 432–8.CrossRefGoogle Scholar
22
22.Smith, GRJr, Monson, RA, Ray, DC. Patients with multiple unexplained symptoms. Their characteristics, functional health, and health care utilisation. Arch Intern Med1986; 146(1): 69–72.CrossRefGoogle Scholar
23
23.Bass, C, Murphy, M. Somatisation disorder in a British teaching hospital. Br J Clin Pract1991; 45(4): 237–44.CrossRefGoogle Scholar
24
24.Barsky, AJ, Orav, EJ, Bates, DW. Somatisation increases medical utilisation and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry2005; 62(8): 903–10.CrossRefGoogle ScholarPubMed
25
25.Bass, C, Peveler, R, House, A. Somatoform disorders: severe psychiatric illnesses neglected by psychiatrists. Br J Psychiatry2001; 179: 11–4.CrossRefGoogle ScholarPubMed
26
26.Benbadis, SR. The problem of psychogenic symptoms: is the psychiatric community in denial?Epilepsy Behav200502; 6(1): 9–14.CrossRefGoogle ScholarPubMed
27
27.Hosaka, et al.General Hospital Psychiatry from the perspective of medical economics. Psychiatry Clin Neuroscience1999; 53(4): 449–53.CrossRefGoogle ScholarPubMed
28
28.Pritchard, Cet al.Two-year prospective study of psychosocial outcomes and a cost-analysis of ‘treatment-as-usual’ versus an ‘enhanced’ (specialist liaison nurse) service for aneurysmal sub arachnoid haemorrhage (ASAH) patients and families. Br J Neurosurg2004; 18(4): 347–56.CrossRefGoogle Scholar
29
29.Strain, JJet al.Cost offset from a psychiatric consultation liaison intervention with elderly hip fracture patients. Am J Psych1991; 148: 1044–1049.Google ScholarPubMed
30
30.Smith, GRJr, Rost, K, Kashner, TM. A trial of the effect of a standardised psychiatric consultation on health outcomes and costs in somatising patients. Arch Gen Psychiatry1995; 52(3): 238–43.CrossRefGoogle Scholar
31
31.Kroenke, K, Swindle, R. Cognitive-behavioral therapy for somatisation and symptom syndromes: a critical review of controlled clinical trials. Psychother Psychosom2000; 69(4): 205–15.CrossRefGoogle ScholarPubMed
32
32.Barsky, AJ, Ahern, DK. Cognitive behavior therapy for hypochondriasis: a randomised controlled trial. JAMA2004; 291: 1464–1470.CrossRefGoogle Scholar
33
33.Shapiro, AP, Teasell, RW. Behavioural interventions in the rehabilitation of acute v. chronic non-organic (conversion/factitious) motor disorders. Br J Psychiatry2004; 185: 140–146.CrossRefGoogle ScholarPubMed
34
34.Muller, T, Mannel, M, Murck, H, Rahlfs, VW. Treatment of somatoform disorders with St. John's wort: a randomised, double-blind and placebo-controlled trial. Psychosom Med2004; 66:538–547.CrossRefGoogle ScholarPubMed
35
35.O'Malley, PG, Jackson, JL, Santoro, Jet al.Antidepressant therapy for unexplained symptoms and symptom syndromes. Journal of Family Practice1999; 48: 980–990.Google ScholarPubMed
36
36.O'Keane, V, Jeffers, A, Moloney, E, and Barry, S. Irish Psychiatric Association survey of psychiatric services in Ireland. Psychiatr Bulletin2004; 28: 364–367.CrossRefGoogle Scholar
37
37.A vision for change. Report of the expert group on mental health policy. Department of Health and Children. Dublin: Ireland, 2006.Google Scholar
38
38.Benbadis, SR, Allen, Hauser W. An estimate of the prevalence of psychogenic non-epileptic seizures. Seizure2000; 9(4): 280–1.CrossRefGoogle ScholarPubMed
39
39.Reuber, M, House, AO, Pukrop, R, Bauer, J, Elger, CE. Somatisation, dissociation and general psychopathology in patients with psychogenic non-epileptic seizures. Epilepsy Res2003; 57(2-3):159–67.CrossRefGoogle ScholarPubMed
40
40.Reuber, M, Elger, CE. Psychogenic nonepileptic seizures: review and update. Epilepsy Behav. 2003;4(3):205–16.CrossRefGoogle ScholarPubMed
41
41.Allanson, J, Bass, C, Wade, DT. Characteristics of patients with persistent severe disability and medicallyunexplained neurological symptoms: a pilot study. J Neurol Neurosurg Psychiatry. 2002;73(3):307–9.CrossRefGoogle Scholar